Renata Company Description

Renata PLC manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh.

Its pharmaceutical products include antimicrobials, anti-hypertensive, anti-angina, anti-diabetic, eye-ear and topical preparation, antigout, NSAID, anti-spasmodic, steroid, anti-osteoporotic, anti-allergic, cardiovascular, CNS, hormone, anti-cancer, oxytocic, anti-fibrinolytic, anti-asthma, expectorant, oral rehydration saline, narcotic analgesic, antipyretic/analgesic, antiemetic, anesthetic, antiviral, and other products.

The company offers lipid lowering, antiulcer, anti-parasitic and anti-protozoal, anti-fungal, anti-tuberculosis, and gastroprokinetic agents; and vitamins and minerals.

Its animal health products comprise antibiotic, cephalosporin, sulphonamides, anthelmintic, antiprotozoal, anti-histaminic, NSAID, glucocorticoid, appetizer and rumenotoric, and metabolic products, as well as vitamin-mineral and anti-fibrinolytic; and anthelmintic, anti-coccidial, anti-gout, electrolyte, nutritional premix, nutrition products, imported, and hormone products, as well as poultry and aqua products, and live and killed vaccines.

In addition, the company provides oncology-based products; agro-based products; poultry products; and consumer products.

The company was formerly known as Pfizer Laboratories (Bangladesh) Limited and changed its name to Renata Limited in 1993.

Renata PLC was incorporated in 1972 and is headquartered in Dhaka, Bangladesh.

Renata PLC

Country	Bangladesh
Founded	1972
Industry	Pharmaceutical Preparations
Employees	7,859
CEO	Syed S. Kabir

Contact Details

Address: Plot No. 1 Dhaka, 1216 Bangladesh
Phone	880 2 800 1450
Website	renata-ltd.com

Stock Details

Ticker Symbol	RENATA
Exchange	Dhaka Stock Exchange
Fiscal Year	July - June
Reporting Currency	BDT
SIC Code	2834

Key Executives

Name	Position
Syed S. Kabir	Chief Executive Officer
Mustafa Aolad	Chief Financial Officer